Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Fungal Lung Diseases

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Fungal Lung Diseases in 1 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagayoshi, M1
Tada, Y1
West, J1
Ochiai, E1
Watanabe, A1
Toyotome, T1
Tanabe, N1
Takiguchi, Y1
Shigeta, A1
Yasuda, T1
Shibuya, K1
Kamei, K1
Tatsumi, K1

Other Studies

1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Fungal Lung Diseases

ArticleYear
Inhalation of Stachybotrys chartarum evokes pulmonary arterial remodeling in mice, attenuated by Rho-kinase inhibitor.
    Mycopathologia, 2011, Volume: 172, Issue:1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cytokines; Disease Models, Animal; Lung; Lun

2011